Ruiter DJ - Search Results

1

Immunohistologic evidence for the malignant potential of congenital melanocytic nevi.

Steijlen PM, Hamm H, van Erp EJ, Johnson JP, Ruiter DJ, Bröcker EB. Steijlen PM, et al. Among authors: ruiter dj. J Invest Dermatol. 1989 Mar;92(3):366-70. doi: 10.1111/1523-1747.ep12277206. J Invest Dermatol. 1989. PMID: 2645372 Free article.

2

Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi.

Ruiter DJ, Dingjan GM, Steijlen PM, van Beveren-Hooyer M, de Graaff-Reitsma C, Bergman W, van Muijen GN, Warnaar SO. Ruiter DJ, et al. J Invest Dermatol. 1985 Jul;85(1):4-8. doi: 10.1111/1523-1747.ep12274479. J Invest Dermatol. 1985. PMID: 3891875 Free article.

3

Macrophages in melanocytic naevi.

Bröcker EB, Reckenfeld C, Hamm H, Ruiter DJ, Sorg C. Bröcker EB, et al. Among authors: ruiter dj. Arch Dermatol Res. 1992;284(3):127-31. doi: 10.1007/BF00372703. Arch Dermatol Res. 1992. PMID: 1380230

4

Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma.

van Vreeswijk H, Ruiter DJ, Bröcker EB, Welvaart K, Ferrone S. van Vreeswijk H, et al. Among authors: ruiter dj. J Invest Dermatol. 1988 May;90(5):755-60. doi: 10.1111/1523-1747.ep12560951. J Invest Dermatol. 1988. PMID: 3283252 Free article.

5

Effects of systemic interferon-alpha (IFN-alpha) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852.

von Stamm U, Bröcker EB, von Depka Prondzinski M, Ruiter DJ, Rümke P, Broding C, Carrel S, Lejeune FJ. von Stamm U, et al. Among authors: ruiter dj. Melanoma Res. 1993 Jun;3(3):173-80. doi: 10.1097/00008390-199306000-00005. Melanoma Res. 1993. PMID: 8104570 Clinical Trial.

6

Immunohistochemistry in the evaluation of melanocytic tumors.

Ruiter DJ, Bröcker EB. Ruiter DJ, et al. Semin Diagn Pathol. 1993 Feb;10(1):76-91. Semin Diagn Pathol. 1993. PMID: 8506418 Review.

7

Monoclonal antibody PAL-M1 recognizes the transferrin receptor and is a progression marker in melanocytic lesions.

van Muijen GN, Ruiter DJ, Hoefakker S, Johnson JP. van Muijen GN, et al. Among authors: ruiter dj. J Invest Dermatol. 1990 Jul;95(1):65-9. doi: 10.1111/1523-1747.ep12873947. J Invest Dermatol. 1990. PMID: 2366002 Free article.

8

Phenotypic dynamics of tumor progression in human malignant melanoma.

Bröcker EB, Suter L, Brüggen J, Ruiter DJ, Macher E, Sorg C. Bröcker EB, et al. Among authors: ruiter dj. Int J Cancer. 1985 Jul 15;36(1):29-35. doi: 10.1002/ijc.2910360106. Int J Cancer. 1985. PMID: 3860479

9

Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections of biopsies.

Suter L, Bröcker EB, Brüggen J, Ruiter DJ, Sorg C. Suter L, et al. Among authors: ruiter dj. Cancer Immunol Immunother. 1983;16(1):53-8. doi: 10.1007/BF00199906. Cancer Immunol Immunother. 1983. PMID: 6556951 Free PMC article.

10

Monoclonal antibody MS-44B reacts with human dendritic, glial and endothelial cells: differential expression of MS-44B antigen by epidermal dendritic cells and by MS-1+ splenic sinusoidal endothelial cells. An immunohistological study.

Goerdt S, Bröcker EB, Redmann K, Ruiter DJ, Gullotta F, Bergmann M, Dämmrich J, Buchholz B, Dietl KH, Göters C, et al. Goerdt S, et al. Among authors: ruiter dj. Pathobiology. 1993;61(1):36-42. doi: 10.1159/000163758. Pathobiology. 1993. PMID: 8216821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

385 results

Search Page